Virginia Retirement Systems Et Al Lexicon Pharmaceuticals, Inc. Transaction History

Virginia Retirement Systems Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$1.75 - $2.3 $191,975 - $252,309	-109,700 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$1.8 - $4.28 $137,520 - $326,992	76,400 Added 229.43%	109,700 $214,000
Q4 2019 Jan 27, 2020	BUY	$3.16 - $5.15 $105,228 - $171,495	33,300 New	33,300 $138,000
Q3 2018 Nov 02, 2018	SELL	$10.32 - $13.06 $323,016 - $408,778	-31,300 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$7.8 - $13.69 $244,140 - $428,497	31,300 New	31,300 $376,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.